Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-M Bouloux

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 3, 1999
Growth hormone deficiency and atherosclerosis--is there a link?S McGrath, M Morris, P M Bouloux
Annals of the New York Academy of Sciences|November 5, 1997
Progress in determining the genes for hypertension, insulin resistance, and dyslipidemiaM Caulfield, P M Bouloux, P Munroe
The Journal of Endocrinology|July 9, 1999
Using skeletal muscle as an artificial endocrine tissueG S MacColl, G Goldspink, P M Bouloux
Clinical Endocrinology|March 1, 1986
Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomasP M Bouloux, A Grossman, G M Besser
Lancet (London, England)|April 14, 1979
Parasagittal meningioma presenting as low-grade glioma on computerised tomographic scanM L Gross, P M Bouloux, N J Legg
Clinical Endocrinology|December 3, 1999
Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormoneR Quinton, P Barnett, P Coskeran, et al.
British Journal of Clinical Pharmacology|August 1, 1996
The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanismsP M Bouloux, S Corsello, M Besser, et al.
The Journal of Endocrinology|June 1, 1992
Sex and smell--an enigma resolvedP M Bouloux, P Munroe, J Kirk, et al.
British Journal of Pharmacology|March 1, 1997
The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in manE Ur, D M Wright, P M Bouloux, et al.
The Journal of Endocrinology|October 1, 1986
An in-situ isolated rat adrenal perfusion system for study of neurally mediated catecholamine secretion: effects of morphine, a Met-enkephalin analogue, and naloxone on catecholamine secretionP M Bouloux, D Perrett, M Sopwith, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 3, 1999
Growth hormone deficiency and atherosclerosis--is there a link?S McGrath, M Morris, P M Bouloux
Annals of the New York Academy of Sciences|November 5, 1997
Progress in determining the genes for hypertension, insulin resistance, and dyslipidemiaM Caulfield, P M Bouloux, P Munroe
The Journal of Endocrinology|July 9, 1999
Using skeletal muscle as an artificial endocrine tissueG S MacColl, G Goldspink, P M Bouloux
Clinical Endocrinology|March 1, 1986
Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomasP M Bouloux, A Grossman, G M Besser
Lancet (London, England)|April 14, 1979
Parasagittal meningioma presenting as low-grade glioma on computerised tomographic scanM L Gross, P M Bouloux, N J Legg
Clinical Endocrinology|December 3, 1999
Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormoneR Quinton, P Barnett, P Coskeran, et al.
British Journal of Clinical Pharmacology|August 1, 1996
The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanismsP M Bouloux, S Corsello, M Besser, et al.
The Journal of Endocrinology|June 1, 1992
Sex and smell--an enigma resolvedP M Bouloux, P Munroe, J Kirk, et al.
British Journal of Pharmacology|March 1, 1997
The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in manE Ur, D M Wright, P M Bouloux, et al.
The Journal of Endocrinology|October 1, 1986
An in-situ isolated rat adrenal perfusion system for study of neurally mediated catecholamine secretion: effects of morphine, a Met-enkephalin analogue, and naloxone on catecholamine secretionP M Bouloux, D Perrett, M Sopwith, et al.
Pageof 8